Sign inGet started

Gruia Gabriela

Insider CIK 1860326 · MTEM Interim Chief Medical Officer, Director · APRE Director · TCRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APRE Aprea Therapeutics, Inc. A Award deriv2026-06-162026-06-1712,555— $012,555SEC↗
APRE Aprea Therapeutics, Inc. A Award2026-06-162026-06-173,135— $04,180SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2026-05-202026-05-2267,000— $067,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2025-06-302025-07-0267,000— $067,000SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2025-06-052025-06-094,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2025-06-052025-06-091,045— $01,045SEC↗
MTEM Molecular Templates, Inc. A Award deriv2024-09-272024-09-301,000— $01,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2024-06-122024-06-1447,500— $047,500SEC↗
MTEM Molecular Templates, Inc. A Award deriv2023-10-272023-10-311,000— $01,000SEC↗
MTEM Molecular Templates, Inc. A Award deriv2023-08-312023-08-3111,666— $011,666SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2023-06-132023-06-1535,000— $035,000SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2023-05-052023-05-0812,500— $012,500SEC↗
MTEM Molecular Templates, Inc. A Award deriv2022-06-032022-06-0615,000— $015,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2022-06-012022-06-039,146— $09,146SEC↗
MTEM Molecular Templates, Inc. A Award deriv2022-03-012022-03-0225,000— $025,000SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2021-07-152021-07-169,146— $09,146SEC↗
TCRX TScan Therapeutics, Inc. A Award deriv2021-07-152021-07-169,146— $09,146SEC↗